These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37941651)

  • 21. Advances in landscape and related therapeutic targets of the prostate tumor microenvironment.
    Li D; Xu W; Chang Y; Xiao Y; He Y; Ren S
    Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(6):956-973. PubMed ID: 37294106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgens modify therapeutic response to cabazitaxel in models of advanced prostate cancer.
    Begemann D; Wang Y; Yang W; Kyprianou N
    Prostate; 2020 Sep; 80(12):926-937. PubMed ID: 32542812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective combinatorial immunotherapy for castration-resistant prostate cancer.
    Lu X; Horner JW; Paul E; Shang X; Troncoso P; Deng P; Jiang S; Chang Q; Spring DJ; Sharma P; Zebala JA; Maeda DY; Wang YA; DePinho RA
    Nature; 2017 Mar; 543(7647):728-732. PubMed ID: 28321130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor microenvironment pH-responsive pentagonal gold prism-based nanoplatform for multimodal imaging and combined therapy of castration-resistant prostate cancer.
    Tan H; Liu Y; Hou N; Cui S; Liu B; Fan S; Yu G; Han C; Zheng D; Li W; Liu Y; Xu B; Wang Z; Cui D
    Acta Biomater; 2022 Mar; 141():408-417. PubMed ID: 35032718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.
    Zhang A; Lau NA; Wong A; Brown LG; Coleman IM; De Sarkar N; Li D; DeLucia DC; Labrecque MP; Nguyen HM; Conner JL; Dumpit RF; True LD; Lin DW; Corey E; Alumkal JJ; Nelson PS; Morrissey C; Lee JK
    Cancer Res Commun; 2023 Nov; 3(11):2358-2374. PubMed ID: 37823778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging therapeutics targeting castration-resistant prostate cancer: the AR-mageddon of tumor epithelial-mesenchymal transition.
    Hendrix LN; Hamilton DA; Kyprianou N
    Expert Rev Endocrinol Metab; 2013 Jul; 8(4):403-416. PubMed ID: 30736155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate Microbiota and Prostate Cancer: A New Trend in Treatment.
    Che B; Zhang W; Xu S; Yin J; He J; Huang T; Li W; Yu Y; Tang K
    Front Oncol; 2021; 11():805459. PubMed ID: 34956913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment landscape of metastatic prostate cancer.
    Yamada Y; Beltran H
    Cancer Lett; 2021 Oct; 519():20-29. PubMed ID: 34153403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Exosomes in Prostate Cancer Metastasis.
    Akoto T; Saini S
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform.
    Lin E; Hahn AW; Nussenzveig RH; Wesolowski S; Sayegh N; Maughan BL; McFarland T; Rathi N; Sirohi D; Sonpavde G; Swami U; Kohli M; Rich T; Sartor O; Yandell M; Agarwal N
    Oncologist; 2021 Sep; 26(9):751-760. PubMed ID: 34157173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Suppressor Element 1 (GSE1) Promotes the Oncogenic and Recurrent Phenotypes of Castration-Resistant Prostate Cancer by Targeting Tumor-Associated Calcium Signal Transducer 2 (TACSTD2).
    Bamodu OA; Wang YH; Ho CH; Hu SW; Lin CD; Tzou KY; Wu WL; Chen KC; Wu CC
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer.
    Kahn B; Collazo J; Kyprianou N
    Int J Biol Sci; 2014; 10(6):588-95. PubMed ID: 24948871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics.
    Chaves LP; Melo CM; Saggioro FP; Reis RBD; Squire JA
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment.
    Livas L; Hasani S; Kyprianou N
    Adv Exp Med Biol; 2020; 1296():183-198. PubMed ID: 34185293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.
    Kurniawati I; Liu MC; Hsieh CL; Do AD; Sung SY
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):256. PubMed ID: 36224011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ADAM9/UBN2/AKR1C3 axis promotes resistance to androgen-deprivation in prostate cancer.
    Le TT; Hsieh CL; Lin IH; Chu CY; Do AD; Chen SH; Shigemura K; Kitagawa K; Fujisawa M; Liu MC; Chen KC; Sung SY
    Am J Cancer Res; 2022; 12(1):176-197. PubMed ID: 35141012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression.
    Kaarijärvi R; Kaljunen H; Ketola K
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33572108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.
    Patel GK; Chugh N; Tripathi M
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of
    Russo JW; Gao C; Bhasin SS; Voznesensky OS; Calagua C; Arai S; Nelson PS; Montgomery B; Mostaghel EA; Corey E; Taplin ME; Ye H; Bhasin M; Balk SP
    Cancer Res; 2018 Nov; 78(22):6354-6362. PubMed ID: 30242112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.